Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Net Cash Flow (2019 - 2025)

Volitionrx's Net Cash Flow history spans 9 years, with the latest figure at $652971.0 for Q4 2025.

  • For Q4 2025, Net Cash Flow rose 119.55% year-over-year to $652971.0; the TTM value through Dec 2025 reached -$2.7 million, up 84.95%, while the annual FY2025 figure was -$2.7 million, 84.95% up from the prior year.
  • Net Cash Flow reached $652971.0 in Q4 2025 per VNRX's latest filing, up from -$2.0 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $13.6 million in Q1 2021 to a low of -$9.0 million in Q3 2023.
  • Average Net Cash Flow over 5 years is -$976706.8, with a median of -$1.4 million recorded in 2023.
  • The largest YoY upside for Net Cash Flow was 354.31% in 2021 against a maximum downside of 4367.05% in 2021.
  • A 5-year view of Net Cash Flow shows it stood at -$2.4 million in 2021, then crashed by 123.58% to -$5.5 million in 2022, then surged by 281.61% to $9.9 million in 2023, then plummeted by 133.7% to -$3.3 million in 2024, then soared by 119.55% to $652971.0 in 2025.
  • Per Business Quant, the three most recent readings for VNRX's Net Cash Flow are $652971.0 (Q4 2025), -$2.0 million (Q3 2025), and -$669448.0 (Q2 2025).